Levacetylleucine (Aqneursa) improved neurologic symptoms and functioning in adults and children with ataxia-telangiectasia in ...
Scientists discovered that a key brain signal may have been pointing researchers in the wrong direction, potentially changing ...
Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today ...
Paraneoplastic neurological syndromes (PNS) associated with triple-negative breast carcinoma (TNBC) are exceptionally rare. We report a case of fulminant encephalitis in a middle-aged woman with TNBC ...
A little-known, rarely described condition, pseudologia fantastica, could be more prevalent and influential than anyone ...
Joubert syndrome (JS) is a rare ciliopathy characterised by the molar tooth sign on brain MRI, cerebellar vermis hypoplasia, hypotonia and developmental delay. We report an elementary school-aged boy ...
Our latest CPD module explores five common but challenging neurology cases encountered in general practice, and discusses evidence-based approaches to assessment, investigation and management.
Raina Heverin, 44, suffered a serious brain injury and was in a coma for a month after the freak accident ...
In the cooperative research and development agreement, the partners will use Apertura's TfR1 CapX capsid to deliver a gene therapy to the central nervous system.
Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
A new generation of therapies aims to intervene at a recently discovered gap between the disease’s molecular march and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results